SPRC
SciSparc Ltd.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
No implied move.
Next report
Last report
—
Largest filed tie
13F top-10 QoQ
—
Top fund weight
—
SciSparc Ltd.
Expected move
No implied move.
Next report
Last report
—
Largest filed tie
13F top-10 QoQ
—
Top fund weight
—
News
Linked news
SentenceIn February 2021, we signed an agreement with The Israeli Medical Center
for Alzheimer's, to conduct a phase IIa clinical trial to evaluate the safety, tolerability and efficacy of SCI-110 in patients
with Alzheimer's disease and agitation using our proprietary cannabinoid-based technology.
SPRC 20-Faccession 0001213900-26-049322
Sentencepay Yissum royalties at the rates of 3% of net sales, subject to the royalty reductions as described in the Yissum License Agreement.
SPRC 20-Faccession 0001213900-26-049322
SciSparc has 5 disclosed suppliers and 1 disclosed customer in SEC filings.
SciSparc Ltd.
0.65